Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases

Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases

Source: 
Yahoo/Zacks.com
snippet: 

Bayer Aktiengesellschaft’s wholly-owned subsidiary, BlueRock Therapeutics LP, FUJIFILM Cellular Dynamics, Inc. and Opsis Therapeutics, LLC, announced that they have entered into a strategic research and development alliance to discover and develop cell therapies for eye diseases.